Defibrotide for the Treatment of Severe COVID-19

NCT04652115 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Defibrotide

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]